Article Information
History
- September 10, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Renu Verma1,2,9,*,
- Kesia Esther da Silva1,
- Neesha Rockwood3,4,5,
- Roeland E. Wasmann8,
- Nombuso Yende6,
- Taeksun Song6,
- Eugene Kim1,
- Paolo Denti8,
- Robert J. Wilkinson3,4,7 and
- Jason R. Andrews1
- 1Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, California, USA
- 2Institute of Bioinformatics, International Tech Park, Bangalore, India
- 3Center for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine and Dept. Medicine, University of Cape Town, Observatory 7925, South Africa
- 4Department of Infectious Diseases, Imperial College, London, W12 0NN, United Kingdom
- 5Department of Medical Microbiology and Immunology, Faculty of Medicine, University of Colombo, Sri Lanka
- 6Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory 7925, South Africa
- 7Francis Crick Institute, London NW1 1AT, United Kingdom
- 8Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa
- 9Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, India
- ↵*Correspondence, Renu Verma, PhD Division of Infectious Diseases and Geographic Medicine Biomedical Innovations Building, Room 3600 Stanford University School of Medicine Stanford, CA 94305 Email: vrenu{at}stanford.edu/renujverma{at}gmail.com Phone: +91 9620446440
Posted September 10, 2023.
A Nanopore sequencing-based pharmacogenomic panel to personalize tuberculosis drug dosing
